Renalytix: Q1 Earnings Insights
Portfolio Pulse from Benzinga Insights
Renalytix (NASDAQ:RNLX) reported Q1 earnings with an EPS of $-0.11, missing estimates by 10.0% and a revenue decrease of $510 thousand from the previous year. The company's past earnings performance shows mixed results with both beats and misses on EPS estimates.
November 14, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Renalytix reported a Q1 EPS of $-0.11, missing estimates by 10%, and a year-over-year revenue decline, indicating potential negative investor sentiment.
Missing earnings estimates and reporting lower revenue compared to the previous year are typically seen as negative indicators for a company's financial health and often lead to a decrease in stock price in the short term. Renalytix's past performance shows that the stock price can be sensitive to earnings reports, as seen by the 5.96% increase after a positive earnings surprise last quarter.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100